Interview: Dr. Lisa Lattanza

Jefferson Award Winner Gives Girls Hands-On Experience In Male-Dominated Fields

“The biggest hurdle will be FDA approval and implementing the technology in a safe and standardized way.”

Dr. Lisa Lattanza’s clinical interests include reconstruction of the adult and pediatric Upper Extremity. She has special interest in congenital problems and post-traumatic elbow reconstruction. She is currently involved in research on the biomechanics of the elbow, congenital elbow problems and flexor tendon rehabilitation. Lattanza, who joined UCSF Medical Center in 1999, received her medical degree from the Medical College of Ohio in Toledo. After completing her residency in orthopedic surgery at the University of Missouri, Kansas City, she served as a fellow in hand surgery at Roosevelt Hospital, Columbia College of Physicians and Surgeons in New York. She also finished additional fellowship training in congenital hand problems at Texas Scottish Rite Hospital for Children in Dallas. She has been Chief of Hand, Elbow and Upper Extremity Surgery at UCSF since 2008 and Fellowship Director of the Hand Surgery Fellowship since 2006. She also is co-founder and President of the Perry Initiative a non-profit organization established to expose young women to the fields of orthopaedic surgery and engineering. Dr. Lattanza will be a speaker for 3DHEALS2017.

Q: What is your vision on the intersection of 3D Printing and healthcare?

A: I would like to see this technology help to bring down the cost of implants while at the same time improving outcomes for patients. I believe that there is also a role for 3D printing for teaching medical students in areas of surgical anatomy, virtual surgery and other applications.

Q: What is the biggest potential impact you see 3D printing (or bioprinting) having on the healthcare industry?

A: If done correctly it can improve outcomes and decrease costs.

Q: What challenges do you see arising in implementing 3D printing (or bioprinting) in healthcare sector or orthopedics in the next 5 years?

A: The biggest hurdle will be FDA approval and implementing the technology in a safe and standardized way.

Q: Who inspires you the most in the 3D printing industry?

A: My first contact with 3D technology was through the company Materialise so I have a bias.